Abstract
Antithrombin-III (AT-III) and factor VIII coagulant (F VIII:C) and antigenic (F VIII:RA) activities have been studied in nine conservatively treated and 26 dialysed uraemic patients. AT-III levels were not significantly different from those of controls in either group. Among dialysed patients, those who had experienced thrombotic occlusions of the vascular accesses could not be distinguished from the remaining patients on the basis of their AT-III levels. Both F VIII:C and F VIII:RA were slightly higher than in controls in conservatively treated patients, but significantly higher in haemodialysed patients, especially in those who had never experienced thrombotic complications of the vascular accesses. No acute changes were observed in either the AT-III or F VIII:C/F VIII:RA ratio in five patients given heparin therapy during a dialytic session or in the interdialytic period. Thus repeated intermittent heparin treatment does not induce a hypercoagulable state in haemodialysed patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Collen D., Schetz J., de Cock F., Holmer E., Verstraete M. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. Eur J Clin Invest. 1977 Feb;7(1):27–35. doi: 10.1111/j.1365-2362.1977.tb01566.x. [DOI] [PubMed] [Google Scholar]
- Denson K. W., Redman C. W. Heparin-induced decrease in circulating antithrombin-III. Lancet. 1977 Nov 12;2(8046):1028–1029. doi: 10.1016/s0140-6736(77)92924-5. [DOI] [PubMed] [Google Scholar]
- Denson K. W. The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res. 1977 Jan;10(1):107–119. doi: 10.1016/0049-3848(77)90084-6. [DOI] [PubMed] [Google Scholar]
- Kaegi A., Pineo G. F., Shimizu A., Trivedi H., Hirsh J., Gent M. Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. N Engl J Med. 1974 Feb 7;290(6):304–306. doi: 10.1056/NEJM197402072900604. [DOI] [PubMed] [Google Scholar]
- Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966 Apr;15(1):45–52. doi: 10.1016/0003-2697(66)90246-6. [DOI] [PubMed] [Google Scholar]
- Mann B. Asbestosis. Lancet. 1977 Dec 10;2(8050):1232–1233. doi: 10.1016/s0140-6736(77)90474-3. [DOI] [PubMed] [Google Scholar]
- Marciniak E., Gockerman J. P. Heparin-induced decrease in circulating antithrombin-III. Lancet. 1977 Sep 17;2(8038):581–584. doi: 10.1016/s0140-6736(77)91429-5. [DOI] [PubMed] [Google Scholar]
- Rabiner S. F. Bleeding in uremia. Med Clin North Am. 1972 Jan;56(1):221–233. doi: 10.1016/s0025-7125(16)32437-3. [DOI] [PubMed] [Google Scholar]
- Redman C. W., Denson K. W., Beilin L. J., Bolton F. G., Stirrat G. M. Factor-VIII consumption in pre-eclampsia. Lancet. 1977 Dec 17;2(8051):1249–1252. doi: 10.1016/s0140-6736(77)92661-7. [DOI] [PubMed] [Google Scholar]
- Remuzzi G., Livio M., Marchiaro G., Mecca G., de Gaetano G. Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron. 1978;22(4-6):347–353. doi: 10.1159/000181474. [DOI] [PubMed] [Google Scholar]
- Remuzzi G., Livio M., Roncaglioni M. C., Mecca G., Donati M. B., de Gaetano G. Bleeding in renal failure: is von Willebrand factor implicated? Br Med J. 1977 Aug 6;2(6083):359–361. doi: 10.1136/bmj.2.6083.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Remuzzi G., Schieppati A., Mecca G. Abnormal platelet function in haemodialysed patients: current concepts. Int J Artif Organs. 1979 May;2(3):109–112. [PubMed] [Google Scholar]
- de Gaetano G., Miragliotta G., Roncucci R., Lansen J., Lambelin G. Suloctidil: a novel inhibitor of platelet aggregation in human beings. Thromb Res. 1976 Mar;8(3):361–371. doi: 10.1016/0049-3848(76)90029-3. [DOI] [PubMed] [Google Scholar]